產(chǎn)品中心

人白介素17(IL17)酶聯(lián)免疫吸附檢測試劑盒

ELK2610

規(guī)格：	價格：
48T	￥1960.00
96T	￥2800.00

下載說明 ①

Overview 文獻(xiàn)

Product name:	Human IL17(Interleukin 17) ELISA Kit
Reactivity:	Human
Alternative Names:	IL-17;IL17A; CTLA8; IL-17A; Cytotoxic T-Lymphocyte-Associated Protein 8
Assay Type:	Sandwich
Sensitivity:	5.5 pg/mL
Standard:	1000 pg/mL
Detection Range:	15.63-1000 pg/mL
Sample Type:	serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Assay Length:	3.5h
Research Area:	Cytokine;Infection immunity;
Test principle:	The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human IL17. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human IL17. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human IL17, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human IL17 in the samples is then determined by comparing the OD of the samples to the standard curve.

Pediatric Health, Medicine and Therapeutics

Utilizing T-Lymphocyte Activation-Related Cytokines to Predict Non-Responsiveness to Treatment in Pediatric Kawasaki Disease

日期：2025-01-13 IF：1.7
Pediatric Health, Medicine and Therapeutics

Utilizing T-Lymphocyte Activation-Related Cytokines to Predict Non-Responsiveness to Treatment in Pediatric Kawasaki Disease

日期：2025-01-17 IF：1.7
Pediatric Health, Medicine and Therapeutics

Utilizing T-Lymphocyte Activation-Related Cytokines to Predict Non-Responsiveness to Treatment in Pediatric Kawasaki Disease

日期：2025-01-17 IF：1.7
Pediatric Health, Medicine and Therapeutics

Utilizing T-Lymphocyte Activation-Related Cytokines to Predict Non-Responsiveness to Treatment in Pediatric Kawasaki Disease

日期：2025-01-17 IF：1.7
Pediatric Health, Medicine and Therapeutics

Utilizing T-Lymphocyte Activation-Related Cytokines to Predict Non-Responsiveness to Treatment in Pediatric Kawasaki Disease

日期：2025-01-17 IF：1.7

標(biāo)準(zhǔn)曲線

Concentration (pg/mL)	OD	Corrected OD
1000.00	2.079	1.984
500.00	1.636	1.541
250.00	1.283	1.188
125.00	0.815	0.720
62.50	0.567	0.472
31.25	0.357	0.262
15.63	0.213	0.118
0.00	0.095	0.000

精密度

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

回收率

Matrices listed below were spiked with certain level of recombinant IL17 and the recovery rates were calculated by comparing the measured value to the expected amount of IL17 in samples.

Matrix	Recovery range	Average
serum(n=5)	83-95%	89%
EDTA plasma(n=5)	96-107%	102%
Heparin plasma(n=5)	85-99%	92%

線性

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of IL17 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.